TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34565369

Group type: EXPERIMENTAL
Intervention: Healthy Conversations intervention (10 biweekly sessions led by trained peer facilitators)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention during the study period)
Number of subjects: 60
Study: 35033043

Group type: EXPERIMENTAL
Intervention: Supervised Training Regimen (STR)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Home-Based Training Regimen (HTR)
Number of subjects: 126
Study: 32142580

Group type: COMPARATOR
Intervention: Traditional maxillary and mandibular dentures (control)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Stud overdentures
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Bar and telescopic overdentures
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Telescopic and stud overdentures
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Implant overdentures
Number of subjects: 18
Study: 34578863

Group type: EXPERIMENTAL
Intervention: Vitamin D3-enriched Gouda-type cheese (5.7 μg of vitamin D3)
Number of subjects: 79
Study: 33080406

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Face bag-mask
Number of subjects: 39
Study: 35921235

Group type: EXPERIMENTAL
Intervention: FIL 200 mg plus MTX
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: FIL 100 mg plus MTX
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: FIL 200 mg
Number of subjects: 56

Group type: COMPARATOR
Intervention: MTX
Number of subjects: 56
Study: 33855215

Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (< 100 g carbohydrates/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High carbohydrate diet (> 250 g carbohydrates/day)
Number of subjects: 10
Study: 32623701

Group type: EXPERIMENTAL
Intervention: Anti-IBS syrup (15 mL, thrice daily for 6 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo syrup (similar preparation without plant extract)
Number of subjects: 70
Study: 35723849

Group type: EXPERIMENTAL
Intervention: Edaravone 30 mg by slow intravenous infusion for three days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (national therapy only)
Number of subjects: 38
Study: 32450057

Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 0

Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 0
Study: 33073779

Group type: EXPERIMENTAL
Intervention: 35% HP
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 6% HP
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 6% HP + CS
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 6% HP + TiO2
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 6% HP + TiO2 + CS
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control (no bleaching)
Number of subjects: 132
Study: 36474005

Group type: EXPERIMENTAL
Intervention: Individualized digital coaching program (6 weeks)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 109
Study: 35716695

Group type: EXPERIMENTAL
Intervention: Ganaxolone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34383325

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with a 980-nm diode laser set at 6.89 W/cm2 energy density, 0.5 W power, and a tip diameter of 10 mm for 15 seconds.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham group (laser handpiece placed but not activated).
Number of subjects: 36
Study: 33073737

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo two-dose vaccination regimens
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Accelerated implementation strategies
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard implementation strategies
Number of subjects: 47
Study: 36088369

Group type: EXPERIMENTAL
Intervention: Cultural safety training for medical students using participatory serious game design
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cultural safety training
Number of subjects: 27
Study: 33629227

Group type: EXPERIMENTAL
Intervention: Netarsudil 0.01%
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02%
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Netarsudil 0.04%
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study: 34578807

Group type: EXPERIMENTAL
Intervention: Soy protein-based supplement
Number of subjects: 30

Group type: COMPARATOR
Intervention: Regular endurance training without protein supplementation
Number of subjects: 30
Study: 36114662

Group type: COMPARATOR
Intervention: Brachial artery responses during hypercapnia with arterial compression (compression arm)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Brachial artery responses during hypercapnia without α₁‐adrenergic receptor blockade (prazosin; 0.05 mg/kg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Brachial artery responses during hypercapnia with α₁‐adrenergic receptor blockade (prazosin; 0.05 mg/kg)
Number of subjects: 14
Study: 33973307

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (nivolumab 1 mg/kg i.v. plus ipilimumab 3 mg/kg i.v. every 3 weeks for four cycles, followed by nivolumab 240 mg i.v. every 2 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nivolumab alone (not specified in the abstract but mentioned for comparison)
Number of subjects: 0
Study: 33187563

Group type: EXPERIMENTAL
Intervention: Resistive Respiratory Muscle Training (RRMT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Endurance Respiratory Muscle Training (ERMT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo Respiratory Muscle Training (PRMT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 24
Study: 34590926

Group type: EXPERIMENTAL
Intervention: Kyusho Jitsu intervention (twice a week for 6 months)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Both groups (intervention and control)
Number of subjects: 51
Study: 32811448

Group type: EXPERIMENTAL
Intervention: Functional training intervention (INT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intradiaytic cycling control (CON)
Number of subjects: 40
Study: 35509219

Group type: EXPERIMENTAL
Intervention: Oral ARD-101 (40, 100, and 240 mg)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Oral ARD-101 (240 mg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 33259073

Group type: EXPERIMENTAL
Intervention: Polypropylene (PP) transobturator slings
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Polyvinylidene fluoride (PVDF) transobturator slings
Number of subjects: 285
Study: 34851740

Group type: EXPERIMENTAL
Intervention: Usual care plus a palliative care intervention (UC+PAL)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 148
Study: 35322475

Group type: EXPERIMENTAL
Intervention: 2% Fish Oil and 3% Rooibos
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 1.5% Rooibos
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fish Oil and 3% Rooibos
Number of subjects: 72

Group type: COMPARATOR
Intervention: 0% Fish Oil and Rooibos-free diets
Number of subjects: 72
Study: 34505368

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 262

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 262
Study: 34378330

Group type: EXPERIMENTAL
Intervention: 34-session singing group programme (SGP)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Active waiting-list control
Number of subjects: 149
Study: 32347887

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 27564

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27564
Study: 35237340

Group type: EXPERIMENTAL
Intervention: Qinghe dispel paralysis soup
Number of subjects: 116

Group type: COMPARATOR
Intervention: Loxoprofen sodium dispersible tablets
Number of subjects: 116
Study: 33686482

Group type: EXPERIMENTAL
Intervention: Early sedation with dexmedetomidine (DEX)
Number of subjects: 3904

Group type: COMPARATOR
Intervention: Usual care sedation
Number of subjects: 3904
Study: 32183831

Group type: EXPERIMENTAL
Intervention: Collagen sponge insertion
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control
Number of subjects: 31
Study: 33849908

Group type: EXPERIMENTAL
Intervention: Wearing a cloth face mask during exercise
Number of subjects: 31

Group type: COMPARATOR
Intervention: No cloth face mask during exercise
Number of subjects: 31
Study: 33482328

Group type: EXPERIMENTAL
Intervention: Alpha-synuclein (αS)
Number of subjects: 0
Study: 32810203

Group type: EXPERIMENTAL
Intervention: 50W ablation group
Number of subjects: 150

Group type: COMPARATOR
Intervention: 30W ablation group
Number of subjects: 150

Group type: COMPARATOR
Intervention: 40W ablation group
Number of subjects: 150
Study: 34191064

Group type: EXPERIMENTAL
Intervention: Adjuvant Stereotactic Radiosurgery (SRS) after surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant Stereotactic Radiosurgery (SRS) before resection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postoperative observation after tumor removal
Number of subjects: 0
Study: 32266730

Group type: EXPERIMENTAL
Intervention: Gamified education
Number of subjects: 271

Group type: COMPARATOR
Intervention: Traditional ABCDEs education (Control)
Number of subjects: 271
Study: 35532031

Group type: EXPERIMENTAL
Intervention: Endovenous laser flush ablation (EVLAf) starting from the sapheno-femoral junction (SFJ)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard ablation (EVLAs) starting two cm below the SFJ
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Endovenous laser flush ablation (EVLAf)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard ablation (EVLAs)
Number of subjects: 146
Study: 33340729

Group type: EXPERIMENTAL
Intervention: Class II foot-sparing compression sleeves for the full leg
Number of subjects: 187

Group type: COMPARATOR
Intervention: Class II stockings
Number of subjects: 187
Study: 33734171

Group type: EXPERIMENTAL
Intervention: Narrow band CE-Chirp (NB CE-Chirp) at 500 Hz
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Narrow band CE-Chirp (NB CE-Chirp) at 1000 Hz
Number of subjects: 21
Study: 32054300

Group type: EXPERIMENTAL
Intervention: Transition program for adolescents with chronic conditions
Number of subjects: 0
Study: 34129467

Group type: EXPERIMENTAL
Intervention: Propiverine hydrochloride
Number of subjects: 104
Study: 35864493

Group type: EXPERIMENTAL
Intervention: Resilience educational intervention (8 training sessions using training clips, audio transmissions, and podcasts)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 32935954

Group type: EXPERIMENTAL
Intervention: Motor program activating therapy (MPAT), 1 hour, twice a week for two months.
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Vojta reflex locomotion (VRL), 1 hour, twice a week for two months.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Healthy controls, underwent one fMRI examination.
Number of subjects: 38
Study: 35081280

Group type: EXPERIMENTAL
Intervention: Tofacitinib (5 mg twice daily)
Number of subjects: 4352

Group type: EXPERIMENTAL
Intervention: Tofacitinib (10 mg twice daily)
Number of subjects: 4352

Group type: COMPARATOR
Intervention: TNF inhibitor
Number of subjects: 4352
Study: 32790454

Group type: EXPERIMENTAL
Intervention: Videoconference-delivered single-session pain intervention
Number of subjects: 27

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 27
Study: 34370282

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics (SGA)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Psychiatric comorbidity
Number of subjects: 620
Study: 35012871

Group type: EXPERIMENTAL
Intervention: Forced-air warming blankets
Number of subjects: 67

Group type: COMPARATOR
Intervention: 100% cotton blankets
Number of subjects: 67
Study: 33620516

Group type: EXPERIMENTAL
Intervention: Primary diagnostic codes for RA
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Combination of a diagnostic RA code with biologic infusion codes
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Rheumatologist-reported diagnoses and ACR/EULAR classification criteria
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: ACR/EULAR classification criteria
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Hospital discharge diagnostic codes
Number of subjects: 87
Study: 35333616

Group type: EXPERIMENTAL
Intervention: Antireflux gastric bypass (ARGB)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Fundoplication
Number of subjects: 56
Study: 32901996

Group type: EXPERIMENTAL
Intervention: 15°C PCM treatment covering the quadriceps for three hours
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 33831022

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Mind-body breathing (MBB)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Education control (EDU)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: All groups (TC, MBB, EDU)
Number of subjects: 123
Study: 35193609

Group type: COMPARATOR
Intervention: Bovine milk-based formula containing L. reuteri DSM 17938 at 1 × 10^7 CFU/g (Control Group; CG)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Bovine milk-based formula with added 1.0 g/L 2'FL (Experimental Group; EG)
Number of subjects: 289
Study: 36468967

Group type: EXPERIMENTAL
Intervention: 1.4% silymarin cream
Number of subjects: 25

Group type: COMPARATOR
Intervention: 2% hydroquinone cream
Number of subjects: 25
Study: 32649390

Group type: EXPERIMENTAL
Intervention: Azithromycin (1%) eyedrops
Number of subjects: 36

Group type: COMPARATOR
Intervention: Preservative‐free artificial tears (control group)
Number of subjects: 36
Study: 32233208

Group type: EXPERIMENTAL
Intervention: Compound Amino Acid Capsules (CAAC) combined with clomiphene for 12 weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Clomiphene only for 12 weeks
Number of subjects: 104
Study: 35963826

Group type: COMPARATOR
Intervention: Standard Xpert/no chest radiography (CXR)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Standard Xpert/CXR
Number of subjects: 640

Group type: COMPARATOR
Intervention: Xpert Ultra/no CXR
Number of subjects: 640

Group type: COMPARATOR
Intervention: Xpert Ultra/CXR
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Xpert Ultra (Arms 3 and 4)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: X-ray group (Arms 2 and 4)
Number of subjects: 640
Study: 33567135

Group type: EXPERIMENTAL
Intervention: Subcuticular suturing and early scar management with non‐ablative fractional laser (NAFL) and intralesional triamcinolone injection (ILI)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Tissue adhesive only
Number of subjects: 126

Group type: COMPARATOR
Intervention: Skin closure with tissue adhesive and early scar management
Number of subjects: 126
Study: 33595631

Group type: EXPERIMENTAL
Intervention: Hybrid minimally invasive esophagectomy (HMIE)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Open esophagectomy
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Major intraoperative and postoperative complications
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Major pulmonary complications
Number of subjects: 207
Study: 32128725

Group type: EXPERIMENTAL
Intervention: Allogeneic hematopoietic cell transplantation (alloHCT)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 440
Study: 33620301

Group type: EXPERIMENTAL
Intervention: Mortality salience condition
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 146
Study: 34593040

Group type: EXPERIMENTAL
Intervention: Make Safe Happen® app
Number of subjects: 5032
Study: 33593156

Group type: EXPERIMENTAL
Intervention: Group-based memory rehabilitation intervention
Number of subjects: 24
Study: 34890063

Group type: EXPERIMENTAL
Intervention: Exercise training program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard clinical care
Number of subjects: 28
Study: 32164719

Group type: EXPERIMENTAL
Intervention: Electroacupuncture on HT 7
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Electroacupuncture on SP 6
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Electroacupuncture on HT 7 and SP 6
Number of subjects: 120

Group type: COMPARATOR
Intervention: Compensatory acupuncture therapy (Control)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Polysomnography (secondary outcome)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Biomarker measurements (secondary outcome)
Number of subjects: 120
Study: 34989824

Group type: EXPERIMENTAL
Intervention: Aripiprazole once-monthly (AOM) at 400 mg
Number of subjects: 436

Group type: COMPARATOR
Intervention: Oral aripiprazole at 10-20 mg
Number of subjects: 436

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 436
Study: 32183750

Group type: EXPERIMENTAL
Intervention: Achieved lenticule thickness measured with ultrasound pachymetry
Number of subjects: 184

Group type: COMPARATOR
Intervention: Predicted lenticule thickness
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: ΔLT
Number of subjects: 184
Study: 35974668

Group type: EXPERIMENTAL
Intervention: CTC 200 mg BID
Number of subjects: 1138

Group type: COMPARATOR
Intervention: Tramadol 100 mg QID
Number of subjects: 1138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1138
Study: 36122660

Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Eye drops
Number of subjects: 524
Study: 33066805

Group type: EXPERIMENTAL
Intervention: Moodbuster Lite with automated support delivered by a virtual coach
Number of subjects: 70

Group type: COMPARATOR
Intervention: Moodbuster Lite without automated support
Number of subjects: 70
Study: 35174869

Group type: EXPERIMENTAL
Intervention: Intensive circuit class therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 34833364

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) combined with visual cueing training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS combined with visual cueing training
Number of subjects: 30
Study: 32075673

Group type: EXPERIMENTAL
Intervention: multicomponent training associated with active tDCS
Number of subjects: 28

Group type: COMPARATOR
Intervention: multicomponent training associated with sham tDCS
Number of subjects: 28
Study: 36456965

Group type: EXPERIMENTAL
Intervention: eAEP (online education program)
Number of subjects: 100

Group type: COMPARATOR
Intervention: usual care (including referral to fAEP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: eAEP
Number of subjects: 100
Study: 36334895

Group type: EXPERIMENTAL
Intervention: Feedback on radiation protection performance after each case (n=12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No feedback on radiation protection performance (Control group, n=12)
Number of subjects: 24
Study: 32530343

Group type: EXPERIMENTAL
Intervention: vNOTES hysterectomy
Number of subjects: 99

Group type: COMPARATOR
Intervention: TLH hysterectomy
Number of subjects: 99
Study: 35862105

Group type: EXPERIMENTAL
Intervention: VR-based interactive cognitive training (VICT) system
Number of subjects: 26
Study: 33745454

Group type: EXPERIMENTAL
Intervention: Moderate-intensity fitness training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-intensity exercise (Control)
Number of subjects: 20
Study: 32302322

Group type: EXPERIMENTAL
Intervention: Indemnity (conditional cash transfers)
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Standard insurance
Number of subjects: 3000
Study: 34953634

Group type: EXPERIMENTAL
Intervention: Fresh mango consumption (100 kcal/d)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Isocaloric low-fat cookies (100 kcal/d)
Number of subjects: 27
Study: 34965036

Group type: EXPERIMENTAL
Intervention: Early precut fistulotomy (5 minutes after failed standard biliary cannulation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Late precut fistulotomy (15 minutes after failed standard biliary cannulation)
Number of subjects: 40
Study: 33783006

Group type: EXPERIMENTAL
Intervention: Re-treatment with pan-genotypic DAA (sofosbuvir and velpatasvir with or without ribavirin)
Number of subjects: 40
Study: 36214029

Group type: EXPERIMENTAL
Intervention: Online learning (2020)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Traditional learning (2021)
Number of subjects: 98
Study: 32016881

Group type: EXPERIMENTAL
Intervention: Better sleep quality
Number of subjects: 1444

Group type: EXPERIMENTAL
Intervention: Shorter time to fall asleep
Number of subjects: 1444
Study: 32192917

Group type: EXPERIMENTAL
Intervention: Monitored Anesthesia Care (MAC)
Number of subjects: 3110

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 3110
Study: 34558198

Group type: EXPERIMENTAL
Intervention: Commercial funding
Number of subjects: 6841

Group type: COMPARATOR
Intervention: Unpublished data on funding source
Number of subjects: 6841
Study: 34343240

Group type: EXPERIMENTAL
Intervention: Synthetic control method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unexposed controls
Number of subjects: 0
Study: 32532767

Group type: EXPERIMENTAL
Intervention: Accredited general practice (recent accreditation)
Number of subjects: 3609

Group type: EXPERIMENTAL
Intervention: Accredited general practice (previous accreditation)
Number of subjects: 3609

Group type: EXPERIMENTAL
Intervention: Accredited general practice (2016)
Number of subjects: 3609

Group type: EXPERIMENTAL
Intervention: Accredited general practice (2017)
Number of subjects: 3609
Study: 36472389

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole-brain radiation therapy (WBRT)
Number of subjects: 0
Study: 33617632

Group type: EXPERIMENTAL
Intervention: ATX-101
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 32723925

Group type: EXPERIMENTAL
Intervention: Rotary exercise program
Number of subjects: 31

Group type: COMPARATOR
Intervention: Traditional 'core' exercise program
Number of subjects: 31
Study: 34741341

Group type: EXPERIMENTAL
Intervention: Dietary mulberry-leaf flavonoids (MF) 30 mg/kg
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Dietary mulberry-leaf flavonoids (MF) 60 mg/kg
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Dietary mulberry-leaf flavonoids (MF)
Number of subjects: 270